185.77
-0.94 (-0.50%)
| 前收盘价格 | 186.70 |
| 收盘价格 | 183.84 |
| 成交量 | 558,243 |
| 平均成交量 (3个月) | 2,059,747 |
| 市值 | 30,536,394,752 |
| 市盈率 (P/E TTM) | 34.21 |
| 预期市盈率 (P/E Forward) | 20.92 |
| 价格/销量 (P/S) | 9.68 |
| 股市价格/股市净资产 (P/B) | 4.22 |
| 52周波幅 | |
| 利润日期 | 27 May 2026 |
| 营业毛利率 | 27.34% |
| 营业利益率 (TTM) | 30.79% |
| 稀释每股收益 (EPS TTM) | 4.70 |
| 季度收入增长率 (YOY) | 16.70% |
| 季度盈利增长率 (YOY) | 41.20% |
| 总债务/股东权益 (D/E MRQ) | 1.24% |
| 流动比率 (MRQ) | 4.61 |
| 营业现金流 (OCF TTM) | 1.20 B |
| 杠杆自由现金流 (LFCF TTM) | 1.05 B |
| 资产报酬率 (ROA TTM) | 6.90% |
| 股东权益报酬率 (ROE TTM) | 14.06% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Health Information Services (US) | 看跌 | 看跌 |
| Health Information Services (全球的) | 看跌 | 看跌 | |
| 股票 | Veeva Systems Inc. | 看跌 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 4.0 |
| 内部交易活动 | -1.5 |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 1.20 |
|
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company. |
|
| 部门 | Healthcare |
| 行业 | Health Information Services |
| 投资方式 | Mid Growth |
| 内部持股比例 | 8.55% |
| 机构持股比例 | 86.32% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Linonia Partnership Lp | 31 Dec 2025 | 2,800,018 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 317.00 (Wells Fargo, 70.65%) | 购买 |
| 中 | 270.00 (45.35%) | |
| 低 | 215.00 (Morgan Stanley, 15.74%) | 保留 |
| 平均值 | 265.07 (42.69%) | |
| 总计 | 11 购买, 4 保留 | |
| 平均价格@调整类型 | 192.32 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Citigroup | 09 Mar 2026 | 291.00 (56.65%) | 购买 | 195.57 |
| Canaccord Genuity | 05 Mar 2026 | 235.00 (26.50%) | 保留 | 196.06 |
| Evercore ISI Group | 05 Mar 2026 | 240.00 (29.20%) | 保留 | 196.06 |
| Morgan Stanley | 05 Mar 2026 | 215.00 (15.74%) | 保留 | 196.06 |
| 17 Feb 2026 | 205.00 (10.35%) | 保留 | 176.82 | |
| Needham | 05 Mar 2026 | 270.00 (45.34%) | 购买 | 196.06 |
| Piper Sandler | 05 Mar 2026 | 285.00 (53.42%) | 购买 | 196.06 |
| RBC Capital | 05 Mar 2026 | 275.00 (48.04%) | 购买 | 196.06 |
| Stifel | 05 Mar 2026 | 245.00 (31.89%) | 购买 | 196.06 |
| 26 Feb 2026 | 212.00 (14.12%) | 购买 | 182.86 | |
| TD Cowen | 05 Mar 2026 | 300.00 (61.49%) | 购买 | 196.06 |
| Truist Securities | 05 Mar 2026 | 262.00 (41.04%) | 购买 | 196.06 |
| UBS | 05 Mar 2026 | 220.00 (18.43%) | 保留 | 196.06 |
| 20 Feb 2026 | 200.00 (7.66%) | 保留 | 180.31 | |
| Wells Fargo | 05 Mar 2026 | 317.00 (70.65%) | 购买 | 196.06 |
| Barclays | 25 Feb 2026 | 250.00 (34.58%) | 购买 | 176.46 |
| Oppenheimer | 24 Feb 2026 | 275.00 (48.04%) | 购买 | 175.79 |
| JP Morgan | 20 Feb 2026 | 296.00 (59.34%) | 购买 | 180.31 |
| 显示更多 | ||||
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| SCHWENGER THOMAS D. | - | 196.06 | -1,000 | -196,060 |
| 累积净数量 | -1,000 | |||
| 累积净值 ($) | -196,060 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 196.06 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| SCHWENGER THOMAS D. | 职员 | 05 Mar 2026 | 自动卖出 (-) | 1,000 | 196.06 | 196,060 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合